A detailed history of Richardson Financial Services Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Richardson Financial Services Inc. holds 307 shares of EXEL stock, worth $11,576. This represents 0.01% of its overall portfolio holdings.

Number of Shares
307
Holding current value
$11,576
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 24, 2025

BUY
$34.13 - $46.26 $10,477 - $14,201
307 New
307 $13.4 Million
Q1 2024

May 03, 2024

BUY
$20.17 - $23.93 $6,595 - $7,825
327 New
327 $7.76 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $12.1B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Richardson Financial Services Inc. Portfolio

Follow Richardson Financial Services Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richardson Financial Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Richardson Financial Services Inc. with notifications on news.